Human X‐Box binding protein‐1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines
Author:
Affiliation:
1. Department of Oncology and Lombardi Comprehensive Cancer CenterGeorgetown University School of MedicineWashingtonDCUSA
2. Department of Physiology and BiophysicsGeorgetown University School of MedicineWashingtonDCUSA
Funder
U.S. Department of Defense
Medical Research and Materiel Command
Publisher
Wiley
Subject
Genetics,Molecular Biology,Biochemistry,Biotechnology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.06-7990com
Reference74 articles.
1. Cellular and molecular pharmacology of antiestrogen action and resistance;Clarke R.;Pharmacol. Rev.,2001
2. Tamoxifen for early breast cancer: an overview of the randomised trials
3. Polychemotherapy for early breast cancer: an overview of the randomised trials
4. Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer
5. Fulvestrant, Formerly ICI 182,780, Is as Effective as Anastrozole in Postmenopausal Women With Advanced Breast Cancer Progressing After Prior Endocrine Treatment
Cited by 155 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. miRNA-378 Is Downregulated by XBP1 and Inhibits Growth and Migration of Luminal Breast Cancer Cells;International Journal of Molecular Sciences;2023-12-22
2. Activation of kappa opioid receptor (KOR) inhibits estrogen receptor (ER)-positive breast cancer through the KOR-ER-XBP1 pathway;Biomedicine & Pharmacotherapy;2023-11
3. LINC1521 and miR-3679-5p modulate cellular response to chemical stress in breast cancer patients through regulation of XBP1 expression as a potential diagnostic biomarker;2023-08-11
4. Autophagy and Breast Cancer: Connected in Growth, Progression, and Therapy;Cells;2023-04-14
5. RRM2 and CDC6 are novel effectors of XBP1-mediated endocrine resistance and predictive markers of tamoxifen sensitivity;BMC Cancer;2023-03-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3